169 related articles for article (PubMed ID: 7262141)
1. A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in mice.
Jones TR; Calvert AH; Jackman AL; Brown SJ; Jones M; Harrap KR
Eur J Cancer (1965); 1981 Jan; 17(1):11-9. PubMed ID: 7262141
[No Abstract] [Full Text] [Related]
2. Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics.
Jackman AL; Calvert AH; Hart LI; Harrap KR
Adv Exp Med Biol; 1984; 165 Pt B():375-8. PubMed ID: 6720434
[No Abstract] [Full Text] [Related]
3. Biochemical and antitumor effects of 5,8-dideazaisopteroylglutamate, a unique quinazoline inhibitor of thymidylate synthase.
Fernandes DJ; Bertino JR; Hynes JB
Cancer Res; 1983 Mar; 43(3):1117-23. PubMed ID: 6825083
[No Abstract] [Full Text] [Related]
4. Substituted-2-desamino-2-methyl-quinazolinones. A series of novel antitumour agents.
Boyle FT; Matusiak ZS; Hughes LR; Slater AM; Stephens TC; Smith MN; Brown M; Kimbell R; Jackman AL
Adv Exp Med Biol; 1993; 338():585-8. PubMed ID: 8304185
[No Abstract] [Full Text] [Related]
5. Gamma-linked dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8- dideazafolate as antitumour agents.
Jackman AL; Bisset GM; Jodrell DI; Gibson W; Kimbell R; Bavetsias V; Calvert AH; Harrap KR; Stephens TC; Smith MN
Adv Exp Med Biol; 1993; 338():579-84. PubMed ID: 8304184
[TBL] [Abstract][Full Text] [Related]
6. Quinazoline antifolates inhibiting thymidylate synthase: synthesis of gamma-linked peptide and amide analogues of 2-desamino-2-methyl-N10-propargyl- 5,8-dideazafolic acid (ICI 198583).
Bavetsias V; Jackman AL; Thornton TJ; Pawelczak K; Boyle FT; Bisset GM
Adv Exp Med Biol; 1993; 338():593-6. PubMed ID: 8304188
[No Abstract] [Full Text] [Related]
7. Design and synthesis of Cyclopenta[g]quinazoline-based antifolates as inhibitors of thymidylate synthase and potential antitumor agents(,).
Bavetsias V; Marriott JH; Melin C; Kimbell R; Matusiak ZS; Boyle FT; Jackman AL
J Med Chem; 2000 May; 43(10):1910-26. PubMed ID: 10821704
[TBL] [Abstract][Full Text] [Related]
8. Plasma nucleoside and base levels following treatment with the new thymidylate synthetase inhibitor CB 3717.
Taylor GA; Jackman AL; Calvert AH; Harrap KR
Adv Exp Med Biol; 1984; 165 Pt B():379-82. PubMed ID: 6720435
[No Abstract] [Full Text] [Related]
9. Quinazoline antifolate thymidylate synthase inhibitors: 2'-fluoro-N10-propargyl-5,8-dideazafolic acid and derivatives with modifications in the C2 position.
Jackman AL; Marsham PR; Thornton TJ; Bishop JA; O'Connor BM; Hughes LR; Calvert AH; Jones TR
J Med Chem; 1990 Nov; 33(11):3067-71. PubMed ID: 2231607
[TBL] [Abstract][Full Text] [Related]
10. Quinazoline antifolate thymidylate synthase inhibitors: gamma-linked L-D, D-D, and D-L dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
Bavetsias V; Jackman AL; Kimbell R; Gibson W; Boyle FT; Bisset GM
J Med Chem; 1996 Jan; 39(1):73-85. PubMed ID: 8568829
[TBL] [Abstract][Full Text] [Related]
11. Quinazoline antifolate thymidylate synthase inhibitors: replacement of glutamic acid in the C2-methyl series.
Marsham PR; Jackman AL; Barker AJ; Boyle FT; Pegg SJ; Wardleworth JM; Kimbell R; O'Connor BM; Calvert AH; Hughes LR
J Med Chem; 1995 Mar; 38(6):994-1004. PubMed ID: 7699716
[TBL] [Abstract][Full Text] [Related]
12. Use of murine L5178Y lymphoma thymidine kinase mutants for in vitro and in vivo antitumour efficacy evaluation of novel thymidylate synthase inhibitors.
Stephens TC; Smith MN; Waterman SE; McCloskey ML; Jackman AL; Boyle FT
Adv Exp Med Biol; 1993; 338():589-92. PubMed ID: 8304186
[No Abstract] [Full Text] [Related]
13. Quinazoline analogues of folic acid as inhibitors of thymidylate synthetase from bacterial and mammalian sources.
Scanlon KJ; Moroson BA; Bertino JR; Hynes JB
Mol Pharmacol; 1979 Jul; 16(1):261-9. PubMed ID: 113660
[No Abstract] [Full Text] [Related]
14. Sycnthesis of quinazoline analogues of folic acid modified at postion 10.
Oatis JE; Hynes JB
J Med Chem; 1977 Nov; 20(11):1393-6. PubMed ID: 915899
[TBL] [Abstract][Full Text] [Related]
15. Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717.
Jackman AL; Taylor GA; Calvert AH; Harrap KR
Biochem Pharmacol; 1984 Oct; 33(20):3269-75. PubMed ID: 6487375
[TBL] [Abstract][Full Text] [Related]
16. Quinazoline antifolate thymidylate synthase inhibitors: alkyl, substituted alkyl, and aryl substituents in the C2 position.
Hughes LR; Jackman AL; Oldfield J; Smith RC; Burrows KD; Marsham PR; Bishop JA; Jones TR; O'Connor BM; Calvert AH
J Med Chem; 1990 Nov; 33(11):3060-7. PubMed ID: 2231606
[TBL] [Abstract][Full Text] [Related]
17. The duration of the inhibition of thymidylate synthase in intact L1210 cells exposed to two different classes of quinazoline analogues.
Kimbell R; Jackman AL; Boyle FT; Hardcastle A; Aherne W
Adv Exp Med Biol; 1993; 338():597-600. PubMed ID: 8304189
[No Abstract] [Full Text] [Related]
18. The antitumour activity of ZD9331, a non-polyglutamatable quinazoline thymidylate synthase inhibitor.
Jackman AL; Kimbell R; Brown M; Brunton L; Harrap KR; Wardleworth JM; Boyle FT
Adv Exp Med Biol; 1994; 370():185-8. PubMed ID: 7660886
[No Abstract] [Full Text] [Related]
19. The renewed potential for folate antagonists in contemporary cancer chemotherapy.
Berman EM; Werbel LM
J Med Chem; 1991 Feb; 34(2):479-85. PubMed ID: 1995868
[No Abstract] [Full Text] [Related]
20. Activity of the new antifolate N10-propargyl-5,8-dideazafolate and its polyglutamates against human dihydrofolate reductase, human thymidylate synthetase, and KB cells containing different levels of dihydrofolate reductase.
Cheng YC; Dutschman GE; Starnes MC; Fisher MH; Nanavathi NT; Nair MG
Cancer Res; 1985 Feb; 45(2):598-600. PubMed ID: 3917852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
